Stock Price
6.10
Daily Change
-0.01 -0.16%
Monthly
-3.17%
Yearly
50.25%
Q2 Forecast
6.10

Ardelyx reported $10.85M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Abbott USD 5.3B 380M Mar/2026
Amgen USD 1.6B 187M Mar/2026
Ardelyx USD 10.85M 6.87M Dec/2025
aTyr Pharma USD 3.34M 18.79M Dec/2025
Corcept Therapeutics USD 2.88M 338K Mar/2026
Curis USD 314K 9.96M Dec/2025
Sanofi EUR 3.76B 344M Dec/2025
TG Therapeutics USD 33.51M 4.63M Mar/2026
United Therapeutics USD 133.4M 341.3M Mar/2026
Xoma 116K 112.7K Jun/2024